Real-World Data Support Nivolumab + Ipilimumab for First-Line mRCC Therapy
Study revealed an objective response rate consistent with that observed in the CheckMate 214 clinical trial and a low rate of treatment-related adverse events.
Urology Conferences
Greater PSA Decline Predicts Better 177Lu-PSMA-617 Outcomes in mCRPC
Latest findings are from a post hoc analysis of the phase 3 VISION trial.
Study: 177Lutetium-PSMA-617 After 223Radium for mCRPC Safe, Effective
Treatment with 177lutetium-PSMA-617 (177Lu-PSMA) is safe and effective in patients with metastatic castration-resistant prostate cancer (mCRPC) who have previously received 223radium (223Ra), according to study findings presented at the European Society for Medical Oncology’s 2022 Congress (ESMO 2022) in Paris, France. In a study of 133 patients who participated in the RALU trial, Kambiz Rahbar,…
Survival Improving in Metastatic Castration-Sensitive Prostate Cancer Population
Increase in survival of men with mCSPC during 2015-2019 coincides with the use of docetaxel and novel hormonal therapies for this disease state.
Urinary Incontinence Risk Linked to Thigh Muscle Area in Older Women
Investigators identified the association among community-dwelling adults aged 60 years or older enrolled in the Baltimore Longitudinal Study of Aging.
Tadalafil May Ease Voiding Problems in Women
In a small study, tadalafil, a PDE5 inhibitor used to treated erectile dysfunction, significantly decreased opening urethral pressure in healthy women.
Sacrocolpopexy Complications, Cost Disparities Found
Mesh removal or revision was a top complication across all racial and ethnic groups, investigators reported.
Urethral Dilation Prior to BPH Surgery Lowers Urethral Stricture Risk
Investigators in South Korea demonstrated the benefit in a retrospective study that included 651 men undergoing transurethral resection of the prostate.
BTX-A Safe, Effective for Overactive Bladder in Older Adults
A study of patients older than 70 years who had overactive bladder found that the vast major of them reported improvement urinary incontinence, urinary urgency, daytime urinary frequency, and nighttime frequency after intradetrusor injection of onabotulinumtoxinA.
Age-Related Overactive Bladder Linked to Metabolic Imbalance
BDNF proteolysis imbalance may be a potential biomarker and therapeutic target, new findings suggest.
- Loading...
Loading...
Next post in International Continence Society
Loading... 
Loading...